Zobrazeno 1 - 10
of 273
pro vyhledávání: '"J Erika"'
Autor:
Haydu, J. Erika, Abramson, Jeremy S.
Publikováno v:
In Blood Advances 10 September 2024 8(17):4700-4710
Autor:
Lou, Uvette, Rowen, Brenna, McLaren, Abigail, Kim, E. Bridget, Sorial, Mark N., Haydu, J. Erika, Lei, Matthew M.
Publikováno v:
Pharmacy Practice in Focus: Oncology; Aug2024, Vol. 6 Issue 6, p18-29, 12p
Autor:
Versluis, Jurjen, Pandey, Manu, Flamand, Yael, Haydu, J. Erika, Belizaire, Roger, Faber, Mark, Vedula, Rahul S., Charles, Anne, Copson, Kevin M., Shimony, Shai, Rozental, Alon, Bendapudi, Pavan K., Wolach, Ofir, Griffiths, Elizabeth A., Thompson, James E., Stone, Richard M., DeAngelo, Daniel J., Neuberg, Donna, Luskin, Marlise R., Wang, Eunice S., Lindsley, R. Coleman *
Publikováno v:
In Blood Advances 10 May 2022 6(9):2835-2846
Autor:
Haydu, J. Erika, Maron, Jenny S., Redd, Robert A., Gallagher, Kathleen M.E., Fischinger, Stephanie, Barnes, Jeffrey A., Hochberg, Ephraim P., Johnson, P. Connor, Takvorian, R.W., Katsis, Katelin, Portman, Daneal, Ruiters, Jade, Sechio, Sidney, Devlin, Mary, Regan, Connor, Blumenthal, Kimberly G., Banerji, Aleena, Judd, Allen D., Scorsune, Krista J., McGree, Brianne M., Sherburne, Maryanne M., Lynch, Julia M., Weitzman, James I., Lei, Matthew, Kotton, Camille N., Dighe, Anand S., Maus, Marcela V., Alter, Galit, Abramson, Jeremy S. *, Soumerai, Jacob D. *, *
Publikováno v:
In Blood Advances 22 March 2022 6(6):1671-1683
Autor:
Zuzana Tothova, Anne-Laure Valton, Rebecca A. Gorelov, Mounica Vallurupalli, John M. Krill-Burger, Amie Holmes, Catherine C. Landers, J. Erika Haydu, Edyta Malolepsza, Christina Hartigan, Melanie Donahue, Katerina D. Popova, Sebastian Koochaki, Sergey V. Venev, Jeanne Rivera, Edwin Chen, Kasper Lage, Monica Schenone, Alan D. D’Andrea, Steven A. Carr, Elizabeth A. Morgan, Job Dekker, Benjamin L. Ebert
Publikováno v:
JCI Insight, Vol 6, Iss 3 (2021)
The cohesin complex plays an essential role in chromosome maintenance and transcriptional regulation. Recurrent somatic mutations in the cohesin complex are frequent genetic drivers in cancer, including myelodysplastic syndromes (MDS) and acute myelo
Externí odkaz:
https://doaj.org/article/04d99d4ec50c41c1a8bc57f790a16758
Autor:
J. Erika Haydu, Jeremy S. Abramson
Publikováno v:
Leukemia & Lymphoma. 63:2263-2264
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Erika Haydu, Jenny S. Maron, Robert A. Redd, Kathleen M. E. Gallagher, Stephanie Fischinger, Jeffrey A. Barnes, Ephraim P. Hochberg, P. Connor Johnson, R. W. Takvorian, Katelin Katsis, Daneal Portman, Jade Ruiters, Sidney Sechio, Mary Devlin, Connor Regan, Kimberly G. Blumenthal, Aleena Banerji, Allen D. Judd, Krista J. Scorsune, Brianne M. McGree, Maryanne M. Sherburne, Julia M. Lynch, James I. Weitzman, Matthew Lei, Camille N. Kotton, Anand S. Dighe, Marcela V. Maus, Galit Alter, Jeremy S. Abramson, Jacob D. Soumerai
Publikováno v:
Blood Advances
Chronic lymphocytic leukemia (CLL), the most common leukemia worldwide, is associated with increased COVID-19 mortality. Previous studies suggest only a portion of vaccinated CLL patients develop severe acute respiratory syndrome coronavirus 2 (SARS-
Autor:
Neil R Poulter, Felix A. Barasa, Grace Shedul, David Mukunya, Elijah Ogola, D.B. Ojji, Albertino Damasceno, Brian Rayner, Prossie Merab Ingabire, Mahmoud U Sani, John Mukisa, J Erika, Okechukwu S Ogah, Creole Study Investigators, Anastase Dzudie, C. Mondo
Publikováno v:
European Heart Journal. 42
Background Dipping of blood pressure (BP) at night is a normal physiological phenomenon. However, a non-dipping pattern is associated with hypertension mediated organ damage, secondary forms of hypertension and poorer long-term outcome. Identifying a
Autor:
Rahul S. Vedula, Alon Rozental, Jurjen Versluis, Pavan K. Bendapudi, J. Erika Haydu, Yael Flamand, Manu Pandey, Daniel J. DeAngelo, R. Coleman Lindsley, Shai Shimony, Donna Neuberg, Anne Charles, Richard Stone, Elizabeth A. Griffiths, Eunice S. Wang, James E. Thompson, Roger Belizaire, Marlise R. Luskin, Kevin Copson, Ofir Wolach
Bleeding in patients with acute myeloid leukemia (AML) receiving intensive induction chemotherapy is multifactorial and contributes to early death. We sought to define incidence and risk factors of grade 4 bleeding to support strategies for risk miti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86171c505b03e435590e1e0fccabd624
https://doi.org/10.1101/2021.09.24.21263986
https://doi.org/10.1101/2021.09.24.21263986